Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8586)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 10, 2015 (publication date) through Jul 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cooper BT, Sanfilippo NJ. Concurrent chemoradiation for high-risk prostate cancer. World J Clin Oncol 2015; 6(4): 35-42 [PMID: 26266099 DOI: 10.5306/wjco.v6.i4.35] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v6/i4/35.htm |
| Number | Citing Articles |
| 1 |
Abdulaziz Alhussan, Nolan Jackson, Sarah Eaton, Nancy Dos Santos, Ingrid Barta, Josh Zaifman, Sam Chen, Yuen Yi C. Tam, Sunil Krishnan, Devika B. Chithrani. Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer. Cancers 2022; 14(24): 6137 doi: 10.3390/cancers14246137
|
| 2 |
Yiannis Philippou, Hanna Sjoberg, Alastair D. Lamb, Philip Camilleri, Richard J. Bryant. Harnessing the potential of multimodal radiotherapy in prostate cancer. Nature Reviews Urology 2020; 17(6): 321 doi: 10.1038/s41585-020-0310-3
|
| 3 |
Prakash Paudyal, Qing Xie, Prasanna Kuma Vaddi, Michael D. Henry, Songhai Chen. Inhibiting G protein βγ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel. Oncotarget 2017; 8(22): 36067 doi: 10.18632/oncotarget.16428
|
| 4 |
Sílvia Soares, Fátima Aires, Armanda Monteiro, Gabriela Pinto, Isabel Faria, Goreti Sales, Miguel A. Correa-Duarte, Susana Guerreiro, Rúben Fernandes. Radiotherapy Metastatic Prostate Cancer Cell Lines Treated with Gold Nanorods Modulate miRNA Signatures. International Journal of Molecular Sciences 2024; 25(5): 2754 doi: 10.3390/ijms25052754
|
| 5 |
Rakesh K. Pathak, Uttara Basu, Anis Ahmad, Shrita Sarkar, Anil Kumar, Bapurao Surnar, Saba Ansari, Katarzyna Wilczek, Michael E. Ivan, Brian Marples, Nagesh Kolishetti, Shanta Dhar. A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation. Biomaterials 2018; 187: 117 doi: 10.1016/j.biomaterials.2018.08.062
|
| 6 |
Adam S. Kibel, Jiyoung Ahn, Masis Isikbay, Aleksandra Klim, William S. Wu, Richard B. Hayes, William B. Isaacs, E. Warwick Daw. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. The Prostate 2016; 76(5): 479 doi: 10.1002/pros.23139
|
| 7 |
Yong Luo, Mingchuan Li, Xuemei Zuo, Spyridon Basourakos, Jiao Zhang, Jiahui Zhao, Yili Han, Yunhua Lin, Yongxing Wang, Yongguang Jiang, Ling Lan. β‑catenin nuclear translocation induced by HIF‑1α overexpression leads to the radioresistance of prostate cancer. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4368
|
| 8 |
Shokrieh Hatami Zharabad, Mahshid Mohammadian, Reza Zohdi Aghdam, Mohsen Hassanzadeh Dizaj, Zhaleh Behrouzkia. Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09506-5
|
| 9 |
Zhi Xu, Yanyan Zhang, Jiaji Ding, Weizi Hu, Chunli Tan, Mei Wang, Jinhai Tang, Yong Xu. miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells. Molecular Therapy - Nucleic Acids 2018; 13: 64 doi: 10.1016/j.omtn.2018.08.009
|
| 10 |
Yiannis Philippou, Hanna T. Sjoberg, Emma Murphy, Said Alyacoubi, Keaton I. Jones, Alex N. Gordon-Weeks, Su Phyu, Eileen E. Parkes, W. Gillies McKenna, Alastair D. Lamb, Uzi Gileadi, Vincenzo Cerundolo, David A. Scheiblin, Stephen J. Lockett, David A. Wink, Ian G. Mills, Freddie C. Hamdy, Ruth J. Muschel, Richard J. Bryant. Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model. British Journal of Cancer 2020; 123(7): 1089 doi: 10.1038/s41416-020-0956-x
|
| 11 |
Marte Jonsson, Harald Bull Ragnum, Cathinka Halle Julin, Andree Yeramian, Trevor Clancy, Kari-Anne Myrum Frikstad, Therese Seierstad, Trond Stokke, Xavier Matias-Guiu, Anne Hansen Ree, Kjersti Flatmark, Heidi Lyng. Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition. British Journal of Cancer 2016; 115(8): 929 doi: 10.1038/bjc.2016.278
|
| 12 |
Kyle Bromma, Nancy Dos Santos, Ingrid Barta, Abraham Alexander, Wayne Beckham, Sunil Krishnan, Devika B. Chithrani. Enhancing nanoparticle accumulation in two dimensional, three dimensional, and xenograft mouse cancer cell models in the presence of docetaxel. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17752-5
|
| 13 |
Stephanie Markovina, Marshall W. Meeks, Shahed Badiyan, Joel Vetter, Hiram A. Gay, Alethea Paradis, Jeff Michalski, Gurdarshan Sandhu. Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis. Advances in Radiation Oncology 2018; 3(2): 190 doi: 10.1016/j.adro.2017.12.001
|
| 14 |
Atefeh Satari, Sayed Asadollah Amini, Elham Raeisi, Yves Lemoigne, Esfandiar Heidarian. Synergetic Impact of Combined 5-Fluorouracil and Rutin on Apoptosis in PC3 Cancer Cells through the Modulation of P53 Gene Expression. Advanced Pharmaceutical Bulletin 2019; 9(3): 462 doi: 10.15171/apb.2019.055
|
| 15 |
Keqin Zhou, Yongbao Wei, Xurui Li, Xin Yang. MiR-223-3p targets FOXO3a to inhibit radiosensitivity in prostate cancer by activating glycolysis. Life Sciences 2021; 282: 119798 doi: 10.1016/j.lfs.2021.119798
|
| 16 |
R.E. Clifford, A.D. Gerrard, M. Fok, D. Vimalachandran. Metformin as a radiosensitiser for pelvic malignancy: A systematic review of the literature. European Journal of Surgical Oncology 2021; 47(6): 1252 doi: 10.1016/j.ejso.2020.12.009
|